Position in GH
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,550
+$980 QoQ
Shares Held
17
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#546
of 593 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $65,350 across 19 Diagnostics & Research names. GH ranks #12 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
27 | $10,126 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
15 | $7,520 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
5 | $6,387 | |
| 4 | DHR |
Danaher Corp /De/
|
28 | $5,333 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
8 | $4,211 | |
| 6 | DGX |
Quest Diagnostics Inc
|
19 | $4,027 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
20 | $3,864 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
7 | $3,707 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,550 | 17 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,570 | 17 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,736 | 17 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $687 | 11 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $312 | 6 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $255 | 6 | Shares | Sole | 2025-04-25 | |
| 2023-12-31 | $135 | 5 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||